Immunomedics, Inc. (IMMU)


Stock Price Forecast

Oct. 22, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Immunomedics, Inc. chart...

About the Company

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

Sector

Health Technology

Industry

Biotechnology

Employees

366

Exchange

NASDAQ

Website

http://www.immunomedics.com

$20M

Total Revenue

366

Employees

$18B

Market Capitalization

-51.08

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $IMMU News

Gilead Sciences Inc's Dividend Analysis

5d ago, source:

Gilead Sciences Inc (NASDAQ:GILD) recently announced a dividend of $0.77 per share, payable on 2024-03-28, with the ...

Gilead bets on ‘trispecifics’ in latest cancer drug deal

12d ago, source:

A small partnership with Merus adds to Gilead’s string of cancer dealmaking, which, so far, has not paid off for the large biotech.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...